BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $111 at Stifel
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $66.31 -1.56%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
Stifel analyst Paul Matteis lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $111.00 (from $114.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $88 at Piper Sandler
- Alkem Laboratories Ltd (ALKEM:IN) PT Lowered to INR6,850 at Nomura/Instinet
- Info Edge India (INFOE:IN) PT Raised to INR1,260 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
